MindBio Therapeutics Corp. — Investor Relations & Filings

MindBio Therapeutics Corp. develops and commercializes AI-powered health prediction technologies utilizing proprietary acoustic biomarkers extracted from the human voice. The company's core offering is a comprehensive enterprise platform designed for real-time intoxication and impairment detection, primarily focusing on sobriety verification in safety-critical environments. This platform employs machine learning algorithms to analyze over 140 acoustic parameters, such as jitter, shimmer, and spectral entropy, achieving greater than 88% prediction accuracy in under three seconds. Target markets include zero-tolerance industries like aviation, mining, and construction, requiring scalable, non-invasive fitness-for-duty verification. The technology transforms speech into actionable health intelligence for workforce monitoring and advanced telehealth applications.